David R. McAvoy, General Counsel and CCO at Brickell Biotech, Inc. (BBI), bought 18,124 shares at $0.67 ($12K) on 2021-07-23, disclosed to the SEC on 2021-07-27.
Open-market purchase of $12k BBI by General Counsel and CCO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BBI | BUY | 2021-05-19 | $21K | — | Filing → |
| BBI | BUY | 2020-09-21 | $19K | — | Filing → |